Wordt geladen...
Metabolic engineering of Escherichia coli BL21 (DE3) for de novo production of l-DOPA from d-glucose
BACKGROUND: Production of l-tyrosine is gaining grounds as the market size of 3,4-dihydroxyphenyl-l-alanine (l-DOPA) is expected to increase due to increasing cases of Parkinson’s disease a neurodegenerative disease. Attempts to overproduce l-tyrosine for conversion to l-DOPA has stemmed on the over...
Bewaard in:
| Gepubliceerd in: | Microb Cell Fact |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6482505/ https://ncbi.nlm.nih.gov/pubmed/31023316 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12934-019-1122-0 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|